Most cited papers in Autoimmune and Inflammatory Disorders
What are the most cited papers in Autoimmune and Inflammatory Disorders?
The most cited paper in Autoimmune and Inflammatory Disorders is "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies" (Siew C. Ng, Hai Yun Shi, Nima Hamidi et al., 2017), with 6,147 citations. Next come "Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker" (3,644) and "A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY" (2,993).
Showing 50 of 100 papers. Every paper with more than 565 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Siew C. Ng, Hai Yun Shi, Nima Hamidi et al. · The Lancet | 16 Oct 2017 | 6,147 |
| 2 | Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker Peter P. Bradley, Dennis A. Priebat, Robert D. Christensen et al. · Journal of Investigative Dermatology | Mar 1982 | 3,644 |
| 3 | A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY Richard F. Harvey, J.M. Bradshaw · The Lancet | Mar 1980 | 2,993 |
| 4 | Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease William J. Sandborn, Brian G. Feagan, Paul J. Rutgeerts et al. · New England Journal of Medicine | 21 Aug 2013 | 2,734 |
| 5 | Infliximab Maintenance Therapy for Fistulizing Crohn's Disease Bruce E. Sands, Frank Anderson, Charles Noah Bernstein et al. · New England Journal of Medicine | 25 Feb 2004 | 2,234 |
| 6 | Epidemiology and Natural History of Inflammatory Bowel Diseases Jacques Cosnes, Corinne Gower‐Rousseau, Philippe Seksik et al. · Gastroenterology | May 2011 | 2,226 |
| 7 | Crohn's disease Daniel C. Baumgart, William J. Sandborn · The Lancet | 19 Aug 2012 | 2,153 |
| 8 | Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease Brian G. Feagan et al. · New England Journal of Medicine | 16 Nov 2016 | 1,860 |
| 9 | Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity Jane E. Krawisz, P. Sharon, William F. Stenson · Gastroenterology | Dec 1984 | 1,778 |
| 10 | Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial Stephen B. Hanauer, William J. Sandborn, Paul J. Rutgeerts et al. · Gastroenterology | Feb 2006 | 1,727 |
| 11 | Ulcerative colitis Taku Kobayashi, Britta Siegmund, Catherine Le Berre et al. · Nature Reviews Disease Primers | 10 Sep 2020 | 1,672 |
| 12 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial Wolfgang Hueber et al. · Gut | 17 May 2012 | 1,542 |
| 13 | Pediatric modification of the Montreal classification for inflammatory bowel disease Arie Levine, Anne Marie Griffiths, James F. Markowitz et al. · Inflammatory Bowel Diseases | 8 Nov 2010 | 1,516 |
| 14 | The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria International Team for the Revision of the International Criteria for Behçet's D et al. · Journal of the European Academy of Dermatology and Venereology | 26 Feb 2013 | 1,493 |
| 15 | A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies David R.W. Jayne, Niels Rasmussen, K. Andrássy et al. · New England Journal of Medicine | 2 Jul 2003 | 1,364 |
| 16 | Long-Term Evolution of Disease Behavior of Crohn's Disease Jacques Cosnes, Stéphane Cattan, Antoine Blain et al. · Inflammatory Bowel Diseases | Jul 2002 | 1,353 |
| 17 | Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Ronald J. Falk, Regina S. Terrell, Lucy St Charles et al. · Proceedings of the National Academy of Sciences | Jun 1990 | 1,262 |
| 18 | Inflammatory Bowel Disease Daniel K. Podolsky · New England Journal of Medicine | 26 Sep 1991 | 1,256 |
| 19 | Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial Geert D’Haens et al. · The Lancet | Feb 2008 | 1,243 |
| 20 | Management of Crohn's Disease in Adults Gary R Lichtenstein, Stephen B Hanauer, William J. Sandborn · The American Journal of Gastroenterology | 6 Jan 2009 | 1,185 |
| 21 | Cancer risk in patients with inflammatory bowel disease Charles Noah Bernstein, James Blanchard, Erich V. Kliewer et al. · Cancer | 2001 | 1,170 |
| 22 | The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study William A. Faubion, Edward V. Loftus, William Scott Harmsen et al. · Gastroenterology | Aug 2001 | 1,151 |
| 23 | Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease William J. Sandborn, Christopher Gasink, Long-Long Gao et al. · New England Journal of Medicine | 18 Oct 2012 | 1,141 |
| 24 | A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 Christoph Gasché, Jürgen Schölmerich, Jørn Brynskov et al. · Inflammatory Bowel Diseases | Feb 2000 | 1,139 |
| 25 | Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature Russell W. Read, Gary N. Holland, Narsing A. Rao et al. · American Journal of Ophthalmology | May 2001 | 1,137 |
| 26 | Ulcerative Colitis Silvio Danese, Claudio Fiocchi · New England Journal of Medicine | 2 Nov 2011 | 1,113 |
| 27 | Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Hendrik M. van Dullemen, Sander J. H. van Deventer, Daan W. Hommes et al. · Gastroenterology | Jul 1995 | 1,102 |
| 28 | The Natural History of Adult Crohn's Disease in Population-Based Cohorts Laurent Peyrin‐Biroulet, Edward V. Loftus, Jean‐Frédéric Colombel et al. · The American Journal of Gastroenterology | 27 Oct 2009 | 1,057 |
| 29 | Crohn’s disease Giulia Roda, Siew C. Ng, Paulo Gustavo Kotze et al. · Nature Reviews Disease Primers | 2 Apr 2020 | 1,051 |
| 30 | Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial William J. Sandborn, Stephen B. Hanauer, Paul Rutgeerts et al. · Gut | 13 Feb 2007 | 1,043 |
| 31 | Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease Edouard J. Louis, A Collard, A F Oger et al. · Gut | Dec 2001 | 1,011 |
| 32 | Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardium Kevin Mullane, Rosemary T. Kraemer, Bruce Smith · Journal of Pharmacological Methods | Nov 1985 | 997 |
| 33 | CARD15 mutations in Blau syndrome Corinne Miceli‐Richard, Suzanne Lesage, Michel Rybojad et al. · Nature Genetics | 27 Aug 2001 | 973 |
| 34 | RELAPSING POLYCHONDRITIS LAWRENCE P. McADAM, MICHAEL A. OʼHANLAN, Rodney Bluestone et al. · Medicine | May 1976 | 972 |
| 35 | Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease Paul J. Rutgeerts, Brian G. Feagan, Gary R. Lichtenstein et al. · Gastroenterology | Feb 2004 | 952 |
| 36 | Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial Jean‐Frédéric Colombel et al. · The Lancet | 30 Oct 2017 | 931 |
| 37 | Extraintestinal Manifestations of Inflammatory Bowel Disease Stephan R. Vavricka, Alain M. Schoepfer, Michael M. Scharl et al. · Inflammatory Bowel Diseases | 2 Jul 2015 | 925 |
| 38 | Methotrexate for the Treatment of Crohn's Disease Brian G. Feagan, James Rochon, Richard Neil Fedorak et al. · New England Journal of Medicine | 2 Feb 1995 | 922 |
| 39 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations Gert Van Assche et al. · Journal of Crohn s and Colitis | 22 Dec 2009 | 901 |
| 40 | Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). J Y Mary, R Modigliani · Gut | Jul 1989 | 886 |
| 41 | Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis Philip R Cohen · Orphanet Journal of Rare Diseases | 26 Jul 2007 | 883 |
| 42 | Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management Gerhard Rogler, Abha Goyal Singh, Arthur Kavanaugh et al. · Gastroenterology | 3 Aug 2021 | 878 |
| 43 | Predictors of Crohn’s Disease Laurent Beaugerie, Philippe Seksik, Isabelle Nion–Larmurier et al. · Gastroenterology | Mar 2006 | 867 |
| 44 | Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study Siew C. Ng et al. · Gastroenterology | 9 Apr 2013 | 852 |
| 45 | Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease Filip Baert, Liesbeth Moortgat, Gert Van Assche et al. · Gastroenterology | 9 Oct 2009 | 837 |
| 46 | Acute generalized exanthematous pustulosis (AGEP) – A clinical reaction pattern Alexis Sidoroff, Sima Halevy, Jan Nico Bouwes Bavinck et al. · Journal of Cutaneous Pathology | Mar 2001 | 815 |
| 47 | Natalizumab for Active Crohn's Disease Subrata K. Ghosh, Eran Goldin, Fiona H. Gordon et al. · New England Journal of Medicine | 2003 | 814 |
| 48 | The safety of vedolizumab for ulcerative colitis and Crohn's disease Jean‐Frédéric Colombel, Bruce E. Sands, Paul J. Rutgeerts et al. · Gut | 18 Feb 2016 | 813 |
| 49 | Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen et al. · The American Journal of Gastroenterology | 14 Aug 2012 | 803 |
| 50 | Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort Kelvin Teck Joo Thia, William J. Sandborn, William Scott Harmsen et al. · Gastroenterology | 15 Jul 2010 | 800 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.